قالب وردپرس درنا توس
Home / Business / The Pa company conducting a rapid diagnostic test for COVID-19 will expand operations

The Pa company conducting a rapid diagnostic test for COVID-19 will expand operations



A Pennsylvania company working on a rapid diagnostic test for COVID-19 will expand its manufacturing operations.Gov. Tom Wolf made the announcement Tuesday morning about OraSure Technologies Inc., which is headquartered in Northampton County. The test developed by the company will allow individuals to easily collect a sample and read the results themselves a short time later. “The OraQuick rapid coronavirus antigen self-test would rapidly detect active COVID-19 infection at the sample collection point without any instrument needed to interpret the results and there is no need to transport samples to laboratories for analysis. a lab in a swab, “OraSure President and CEO Stephen S. Tang said. “Importers are important because it will increase our ability to do fast turnaround time testing for Pennsylvanians. It can help us in the future as we look at the new rate,”

; Wolf said. The company hopes the rapid test could be approved by the Food and Drug Administration by the end of the year. OraSure is also conducting a laboratory-based antibody test that would detect previous COVID-19 infection. Officials said OraSure Expansion will create 177 manufacturing jobs in the company’s four Bethlehem locations. Under the Wolf administration, OraSure received a funding proposal from the Department of Community and Economic Development for a $ 531,000 First Pennsylvania grant and $ 531,000 in Job Creation Tax Credits to be distributed to create new jobs.

A Pennsylvania company that is working on a rapid diagnostic test for COVID-19 will expand its manufacturing operations.

Gov. Tom Wolf made the announcement Tuesday morning regarding OraSure Technologies Inc., which is headquartered in Northampton County.

The test developed by the company will allow individuals to easily collect a sample and read the results themselves a short time later.

“Rapid self-test of the OraQuick coronavirus antigen would quickly detect active COVID-19 infection at the collection point without any instrument needed to interpret the results and there is no need to transport samples to laboratories for analysis. is a lab in a swab, “said OraSure President and CEO Stephen S. Tang.

“It’s important because it will enhance our ability to do fast timely return testing for Pennsylvanians. It can help us in the future as we look to the new rate,” Wolf said.

The company hopes the rapid test could be approved by the Food and Drug Administration by the end of the year.

OraSure is also conducting a laboratory-based antibody test that would detect previous COVID-19 infection.

Officials said the expansion of OraSure will create 177 manufacturing jobs in the company’s four Bethlehem locations.

Under the Wolf administration, OraSure received a funding proposal from the Department of Community and Economic Development for a first $ 531,000 grant in Pennsylvania and $ 531,000 in Job Creation Tax Credits to be disbursed after job creation.


Source link